DermLetter.
  • Skin Care & Beauty
  • Skin Conditions
  • Science
  • Trends & Lifestyle
  • Product Reviews
Subscribe
DermLetter.
DermLetter.
  • Skin Care & Beauty
  • Skin Conditions
  • Science
  • Trends & Lifestyle
  • Product Reviews
  • Science

A Hopeful Outlook for Psoriasis Patients

  • December 15, 2016
  • 477 views
psoriasis on knuckles
Total
0
Shares
0
0
0

Dr. Christopher Griffiths, an expert on psoriasis research presented his findings at Dermatology Update 2016. In this interview, he shares the latest findings in psoriasis research and his outlook on dermatology and medicine as a whole.

For psoriasis patients, particularly with moderate and severe involvement, this is significant news, and reason to be delighted. Psoriasis is a chronic disease and one in which treatment and even maintenance have been challenging.

Specific to psoriasis treatment, Dr. Griffiths believes that by taking a translational approach and looking closely at critical cytokines, psoriasis treatment is on the verge of a breakthrough. The next generation of drugs that specifically target interleukin-17 and interleukin-23 looks promising for patients who may be able to get long-term clearance from psoriasis, something that has been elusive up to this point. While short-term clearance of moderate or severe psoriasis (say, over 12-20 weeks) is possible for some, many people eventually have psoriasis recurring at present. For these patients, there may be a reason to believe in a more maintainable clearance.

On a more larger topic, medicine, in general, is undergoing a paradigm shift and heading in the direction of personalized or stratified treatment–that is, a tailored treatment that takes the patient’s uniqueness into account. Currently, treatments are a one size fits all solution–that is, a certain dose of a particular medication is prescribed for patients exhibiting certain symptoms. The problem is that everyone metabolizes medication differently, and many variables are individual and unique. Advances in the genomics, proteomics, transcriptomics–the “omics,” have allowed for the very real possibility for tailored treatments, not just in drug choices and dosing, but also tailored lifestyle advice.

Watch the full interview:

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Related Topics
  • Psoriasis
  • Study
Previous Article
Acne Rosacea pic
  • Skin Conditions

#AskDermLetter: Rosacea and Acne

  • December 15, 2016
View Post
Next Article
checking on toes
  • Science

Nail Fungus Clinical Trials: Efinaconazole

  • January 15, 2017
View Post
Most Popular
  • reflection of woman applying makeup
    Is Beautypedia Legit?
  • Post-Inflammatory Erythema
    Post-Inflammatory Erythema
  • non-comedogenic image
    What does non-comedogenic mean?
  • Do Asians Age Differently?
  • Sunspots
Recent Posts
  • The Value of Sunscreen in Skincare

    View Post
  • woman covering lower face with long hair

    Questions About Melasma and Treatment

    View Post
  • Anti-Aging Checklist

    View Post
  • Beauty Products: Online vs. In-Store

    View Post
  • Eczema & COVID-19 Q&A

    View Post
Our YouTube Channel
https://youtu.be/faKj2X-l4F4

Subscribe

Subscribe now to our newsletter

DermLetter.
  • About
  • Contact
  • Facebook
  • Twitter
  • YouTube
Skin Care Newsletter

Input your search keywords and press Enter.

Go to mobile version